Cargando…
COVID-19-vaccine-Pfizer-BioNTech: Anaphylaxis: 21 case reports
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997522/ http://dx.doi.org/10.1007/s40278-021-93138-y |
Ejemplares similares
-
COVID-19-Vaccine-Pfizer-BioNTech: Anaphylaxis: case report
Publicado: (2022) -
COVID-19-Vaccine-Pfizer-BioNTech: Anaphylaxis to excipient polyethylene glycol: case report
Publicado: (2021) -
Pfizer-BioNTech COVID-19 vaccine-related risk of anaphylaxis
Publicado: (2021) -
Anaphylaxis after Pfizer-BioNTech COVID-19 vaccine in Japan
Publicado: (2021) -
COVID-19-Vaccine-Pfizer-BioNTech: Thyroiditis: case report
Publicado: (2021)